Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of GE-145 vs Iopamidol in Elderly Subjects Undergoing Coronary Catheterization
NCT01252810Phase 2Completed
- Sponsor
- GE HealthCare
- Start
- Nov 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ioforminol in coronary artery disease (CAD), sponsored by GE HealthCare. Started Nov 2010; status: completed.
02
Drugs
ioforminol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01252810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01252810.